Amy Robotics Expands Smart Healthcare Solutions, Serving Nearly 100 Hospitals and Accelerating Global Market Penetration

Recently, Hangzhou AMY Robotics Co., Ltd. (hereinafter referred to as “AMY Robotics”) announced that it has formally entered into a strategic partnership with Haoyiyou Medical Technology Group. Through this collaboration, both parties will fully leverage their respective strengths to jointly promote the widespread adoption of medical robots and support the development of the smart healthcare industry.

Regarding this collaboration, Li Fangyou, Founder & CEO of AMY Robotics, stated that Haoyiyou possesses high-quality medical resources and channels both in China and overseas, offering significant advantages for the market development of AMY Robotics, while AMY Robotics itself can provide Haoyiyou with superior medical products.

AMY Robotics, established in 2015, is an AI-driven innovative enterprise specializing in the research and development, manufacturing, and sales of intelligent service robots and terrestrial cruising robots. With a professional open-source robot service platform, it provides customizable, specialized, and personalized robotic solutions for diverse application scenarios, including healthcare, exhibition halls, and government service centers.

Upon completion of this collaboration, AMY Robotics will continue to advance its product deployment in hospitals and expand into domestic and international markets, while also laying the groundwork for the research and development of rehabilitation robots and minimally invasive surgical robots.

Since the release of “Made in China 2025” in 2015, China has introduced a wide range of supportive policies for the robotics manufacturing industry and related intelligent industries. Government reports have also emphasized leveraging “Intelligence+” to promote the integrated development of advanced manufacturing and modern services.

According to the "2020 Global Robotics Statistics Report," global sales of logistics robots surged by 110% in 2019, while medical robots saw a 28% increase. The COVID-19 pandemic this year has further stimulated the service robotics market, with growing demand for robotic disinfection solutions, factory and warehouse logistics robotics solutions, and last-mile delivery robots.

The favorable market conditions have also intensified competition among companies, with most products becoming increasingly homogeneous. In this regard, Li Fangyou stated that in today’s market environment, the key for a product to stand out lies in ensuring its operational stability and user experience.

Since its inception in 2015, AMY Robotics has been deeply committed to the service robotics sector. By initially focusing on commercial service robots, the company has established a solid technological foundation for the subsequent research and development of medical service robots. Furthermore, prior to its official market launch, AMY’s medical service robots underwent pilot trials at several Grade A tertiary hospitals, thereby validating the product’s safety and stability.

Meanwhile, throughout the product development process, AMY Robotics has consistently integrated user experience to ensure its products are easy to operate, user-friendly, and effective. For customers, the key value of a product lies in its ability to address pain points in specific application scenarios; customer recognition of the product’s solution constitutes its core competitiveness.

When initially selecting a product entry point, Li Fangyou and his team were optimistic about the smart home industry. However, after conducting an in-depth analysis of the sector, they ultimately shifted their focus to the robotics industry.

“We believe that in the future, intelligent robots will be a common sight in every household and community.”

After determining its entrepreneurial direction, AMY Robotics leveraged technologies such as real-time scene mapping, high-precision navigation, and front-end omnidirectional voice optimization to develop the M1 commercial robot for B2B clients and the A1 home robot for C2C consumers. The AMY A1 features human-computer interaction, emotional and behavioral cognition, and remote monitoring capabilities. Meanwhile, the AMY M1 serves both household and commercial sectors, offering a broader scope of application than the A1.

During its development, the AMY Robotics team discovered that in the healthcare industry, many medical professionals are burdened with a large volume of repetitive and tedious tasks. These tasks can be partially automated by intelligent robots. Moreover, compared to other service robots, medical robots feature higher technical barriers, making it easier to establish unique competitive advantages.

Thus, building on existing technologies, AMY Robotics targeted the healthcare sector and developed a series of medical robots featuring functions such as disinfection and supply transportation.

It is reported that AMY Robotics will continue to prioritize the research and development of medical robots, focusing on creating rehabilitation and minimally invasive surgical robots, while also ensuring the iterative updates of its A1 and M1 series robots.

For hospitals, tasks such as disinfection and sterilization, as well as ward rounds with temperature monitoring, are essential. However, these tasks are highly repetitive and involve simple operations, consuming a portion of medical staff’s working hours. The deployment of intelligent robots can automate these tasks, significantly enhancing operational efficiency in these scenarios.

At the outset of the COVID-19 pandemic, AMY Robotics, in collaboration with Zhejiang University and other institutions, rapidly developed a multimodal, high-response intelligent anti-epidemic robot tailored to hospital needs. These robots were urgently deployed to major hospitals in Wuhan. Incorporating professional feedback from healthcare workers, AMY Robotics introduced a series of innovative features designed for the specific scenarios of infectious disease wards, thereby addressing the shortcomings of traditional disinfection and epidemic prevention measures.

In terms of functional coverage, AMY Robotics integrates autonomous navigation, automatic temperature measurement, automated disinfection and sterilization, remote multi-person video consultations, ward-round health education, vital signs monitoring, pharmaceutical and supply delivery, multi-robot coordination, and interactive entertainment. This effectively reduces contact between medical staff and patients, thereby lowering the risk of cross-infection.

In terms of operation, the AMY epidemic prevention robot can achieve fully unmanned operation. Medical staff can issue commands to the robot through a backend group control system, enabling it to perform disinfection tasks along preset routes.

In terms of work efficiency, a single disinfection robot can cover an area of up to 2,000 square meters and is capable of eliminating fungi, bacteria, viruses, and spores.

The current AMY Robotics cannot be fully described merely as a robot R&D company; a more accurate description would be “a provider of holistic solutions for unmanned systems,” i.e., unmanned systems plus robotics.

By developing a centralized cluster-control backend system, AMY Robotics connects robots deployed across different hospital zones with diverse functionalities and integrates them with the Hospital Information System (HIS). Healthcare professionals can directly issue various commands to the robots via the cloud, enabling remote control across different scenarios, enhancing operational efficiency, and achieving human-robot collaboration as well as multi-robot coordination.

During the COVID-19 pandemic, AMY Robotics launched an operating room delivery system and a disinfection system, enabling robots to perform scheduled, location-specific disinfection across operating rooms on various floors with automated dosage control and multi-path mobile disinfection. Additionally, an infrared early-warning system customized for pandemic needs was introduced, capable of temperature screening and attendance check-in during the day, and automatic disinfection at night. By integrating with medical assistant operations, the robots execute diverse commands, replacing 70% of nurses’ routine tasks and significantly alleviating the workload of healthcare professionals.

Currently, AMY Robotics has been deployed in nearly 100 hospitals across China. By introducing AMY robots, the General Hospital of the Eastern Theater Command has established the first hospital ward in China to utilize robotic mobile rounds.

In overseas markets, AMY Robotics has established sales in 32 countries and partnered with more than 20 international distributors. Li Fangyou stated that the intelligent robotics market enjoys significant advantages abroad due to high labor costs and the widespread adoption of unmanned operation concepts. Therefore, AMY will continue to expand its overseas presence while simultaneously strengthening its domestic market. The collaboration with Haoyi You is undoubtedly set to provide substantial support to AMY Robotics’ market expansion strategy.

Henry Huang, Founder and Chairman of Good Doctor Medical Technology Group, stated that medical robots can liberate healthcare professionals from simple, repetitive, time-consuming, and high-risk tasks, allowing them to engage in more valuable and creative endeavors, while simultaneously enhancing efficiency across various medical scenarios. The pandemic this year has comprehensively accelerated the development of medical robots, with AMY Robotics demonstrating outstanding performance in epidemic prevention and control, thereby validating its advantages. Furthermore, AMY Robotics boasts top-tier teams in R&D, corporate management, and sales, along with supply chain strengths, having cultivated deep expertise in the industry for many years. The strategic cooperation with AMY represents a process of complementary advantages for both parties.